Scilex Holding Co
SCLX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q2 2026, worth $5.48M in total; no superinvestor holds it.
Other share classesSCLXW
Q2 2024 vs. Q1 2024
How the institutions holding Scilex Holding Co changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 102 | 1 | 91 | −10 |
| Shares | 28.6M | 56.3K | 39.8M | +11.3M (+39.4%) |
| Value | $45.5M | $89.5K | $76.9M | +$31.5M (+69.3%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Scilex Holding Co at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 11,950,000 | $23.1M | 0.60% |
| Janus Henderson Group PLC | 516,454 | $996.8K | 0.00% |
| Ra Capital Management, L.P. | 261,179 | $504.1K | 0.01% |
| Laurion Capital Management LP | 257,785 | $497.5K | 0.02% |
| UBS Asset Management Americas Inc | 56,284 | $108.6K | 0.00% |
| Corebridge Financial, Inc. | 30,768 | $59.4K | 0.00% |
| Bank of New York Mellon Corp | 15,815 | $30.5K | 0.00% |
| Avantax Advisory Services, Inc. | 15,000 | $28.9K | 0.00% |
| Manufacturers Life Insurance Company, The | 12,935 | $25.0K | 0.00% |
| JustInvest LLC | 11,508 | $22.2K | 0.00% |
| IHT Wealth Management, LLC | 10,000 | $19.3K | 0.00% |
| FMR LLC | 2,896 | $5.59K | 0.00% |
| Jones Financial Companies LLLP | 500 | $965 | 0.00% |
| Painted Porch Advisors LLC | 19 | $37 | 0.00% |
Sold out (24)
Institutions that held Scilex Holding Co at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held Scilex Holding Co at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 56,290 | $89.5K |